Edward Anglin, MD
Orthopaedic Surgery · Shreveport, LANPI 1811991714
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for orthopaedic surgery clinicians in LA, where the typical reported total is $3,274.
Across 15 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vericel Corporation$64
- Innovation Technologies Inc$41
- Nalu Medical, Inc.$39
- Dynasplint Systems Inc.$38
- Abbott$34
- Welch Allyn$25
- plus $117 from 7 others
What the payments were for
- Food & beverage$33393%
- Other$257%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vericel Corporation | 1 | $64 |
| Innovation Technologies Inc | 2 | $41 |
| Nalu Medical, Inc. | 1 | $39 |
| Dynasplint Systems Inc. | 1 | $38 |
| Abbott | 2 | $34 |
| Welch Allyn | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Boston Scientific | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Sanara Medtech Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Solventum Corporation | 1 | $14 |
| Avanos Medical | 1 | $13 |
How this compares
$357 in reported general payments places this provider in the 20th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 35 | $866 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 130 | $732 |
| Meloxicam | 126 | $346 |
| Methylprednisolone | 37 | $213 |
| Tramadol Hcl | 100 | $213 |
| Doxycycline Hyclate | 22 | $154 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $130 |
| Methocarbamol | 22 | $87 |
| Azithromycin | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Shreveport
- Pierce NunleyShreveport$1.8M
- Steven AtchisonShreveport$170K
- Timothy TalbertShreveport$68K
- Mark CallananShreveport$39K
- Michael NammourShreveport$38K
- Eubulus KerrShreveport$33K
- Massimo MorandiShreveport$28K
- John GoogeShreveport$20K
- Christopher CaldwellShreveport$17K
- Christopher HarrodBaton Rouge$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.